|
|
|
Corporate Profile: Medicago
| Summary: |
Medicago is focused on the research and development of vaccines based on its proprietary plant-based Proficia™ manufacturing technology and its Virus-Like Particles (VLPs).
|
| Address (HQ): |
1020, route de l'Église
bureau 600
Québec, QC G1V 3V9
Canada |
| Phone #'s (HQ): |
| Main |
(418) 658-9393 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
(418) 658-6699 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| Mitsubishi Tanabe Pharma acquired Medicago in 2013. |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
